A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn
This post not published yet.

Artificial Intelligence for Drug Discovery -- May 23, 2018, Cambridge, MA USA

Enhanced Tools and Systems to Speed and Multiply Drug Development Pathways

Join industry experts and colleagues at the Artificial Intelligence for Drug Discovery conference on May 23 in Cambridge, MA to discuss the modernization of the drug production process through these disruptive innovations and identify how to extract maximum value from and leverage the massive amounts of data that is continuously being generated. This event is the ideal platform for senior leadership and academia alike to explore critical advancements, exchange solutions, and collaborate with prominent industry thought leaders.

Speaking Faculty Includes:

  •  Novartis
  •  NuMedii
  •  GNS Healthcare
  •  GSK
  •  Biogen
  •  AbbVie
  •  Envisagenics
  •  BERG
  • Cloud Pharmaceuticals
  • EMD Serono
  • BioPharmics LLC

Register or contact a representative:
Matt Hannon  +1-339-298-2157


About the organizer:

CBI, a division of UBM Americas, is a leading business intelligence organization, producing over 130 annual life sciences conferences worldwide.



Share this: